- World rank, all time
- #7,614 of 34,923
- Rank in United States
- #1,581 of 7,310
- Research works
- 152 ▲ 68% vs 2018-21
- Citations
- 11k 72.9 per fractional work
- Top-10% rate
- 19.9% all institutions 10.0%
- vs its own fields
- 1.28× 1.00× is exactly expected
- Open access
- 66% world 40%
- International
- 38% world 18%
Which fields of science does VIR Biotechnology (United States) work in?
In 2022-now, 53% of research at VIR Biotechnology (United States) is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (52%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (8%). It does 2.0× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 21 fields, with their numbers
- Health Sciences2953.1%
- Medicine2851.7%
- Health Professions11.0%
- Veterinary00.5%
- Life Sciences1628.7%
- Physical Sciences814.0%
- Computer Science35.5%
- Engineering24.1%
- Environmental Science11.7%
- Mathematics11.0%
- Materials Science00.7%
- Chemistry00.4%
- Energy00.3%
- Physics and Astronomy00.2%
- Social Sciences24.2%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.5×. Every wedge is a field page.
All 21 fields, with their numbers
- Immunology and Microbiology7.48×4 works
- Veterinary3.76×0 works
- Biochemistry, Genetics and Molecular Biology3.36×10 works
- Medicine2.69×28 works
- Mathematics0.87×1 works
- Computer Science0.71×3 works
- Business, Management and Accounting0.57×1 works
- Agricultural and Biological Sciences0.50×1 works
- Neuroscience0.47×0 works
- Psychology0.42×1 works
- Energy0.36×0 works
- Health Professions0.36×0 works
- Environmental Science0.34×1 works
- Pharmacology, Toxicology and Pharmaceutics0.29×0 works
- Engineering0.27×2 works
- Chemistry0.26×0 works
- Decision Sciences0.21×0 works
- Materials Science0.19×0 works
- Economics, Econometrics and Finance0.16×0 works
- Physics and Astronomy0.09×0 works
- Social Sciences0.04×0 works
- Immunology and Microbiology 7.5×
- Veterinary 3.8×
- Biochemistry, Genetics and Molecular Biology 3.4×
- Medicine 2.7×
- Mathematics 0.9×
- Computer Science 0.7×
- Business, Management and Accounting 0.6×
- Agricultural and Biological Sciences 0.5×
- Neuroscience 0.5×
- Psychology 0.4×
- Energy 0.4×
- Health Professions 0.4×
- Environmental Science 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Engineering 0.3×
- Chemistry 0.3×
- Decision Sciences 0.2×
- Materials Science 0.2×
- Economics, Econometrics and Finance 0.2×
- Physics and Astronomy 0.1×
- Social Sciences 0.0×
Who are the top researchers at VIR Biotechnology (United States)?
Ranked on the quality score, Gyorgy Snell, Florian A. Lempp and Laura E. Rosen lead among researchers whose main affiliation is VIR Biotechnology (United States).
- 1
Gyorgy Snell
United States · #23,035 worldwide 16k citations · 77 works
- 2
Florian A. Lempp
United States · #38,025 worldwide 8k citations · 80 works
- 3
Laura E. Rosen
United States · #68,014 worldwide 10k citations · 46 works
- 4
Lisa A. Purcell
United States · #68,671 worldwide 7k citations · 75 works
- 5
Julia di Iulio
United States · #72,650 worldwide 11k citations · 83 works
- 6
Terri Wrin
United States · #87,287 worldwide 20k citations · 164 works
- 7
Christy M. Hebner
United States · #227,906 worldwide 4.3k citations · 36 works
- 8
Leah B. Soriaga
United States · #285,514 worldwide 4.5k citations · 27 works
- 9
Maria L. Agostini
United States · #300,723 worldwide 6k citations · 30 works
- 10
Martin Borch Jensen
United States · #339,643 worldwide 2k citations · 76 works
Which keywords describe research at VIR Biotechnology (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Pandemic, SARS-CoV-2, Immune Response, ACE2 Receptor, Epidemiology, Vaccine, Immunity and Coronavirus.
- Antigen Presentation
- Interstitial Lung Disease
- Epithelial-Mesenchymal Transition
- Biopharmaceuticals
- TGF-ß
- Hypertrophy
- Liver Disease
- Fc Receptors
- Heart Failure
- Pathophysiology
- Clinical Characteristics
- Thrombosis
- Therapeutic Antibodies
- Monoclonal Antibodies
- antibody
- Inflammation
- Coronavirus
- Vaccine
- Immune Response
- Pandemic
- Epidemiology
- SARS-CoV-2
- ACE2 Receptor
- Immunity
- Viral Transmission
- Mutation
- spike protein
- Pathogenesis
- Glycosylation
- Fibrosis
- Cytokine Storm
- Antiviral Therapy
- Antibody Engineering
- Insulin Resistance
- Hepatocellular Carcinoma
- Innate Immunity
- Immunogenicity
- Cancer Immunotherapy
- Idiopathic Pulmonary Fibrosis
- Mitochondrial Dysfunction
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology8▲ 3.5×31 topics
- Pandemic6▲ 12×6 topics
- SARS-CoV-26▲ 33×3 topics
- Immune Response5▲ 17×11 topics
- ACE2 Receptor5▲ 42×3 topics
- Vaccine5▲ 23×8 topics
- Immunity4▲ 19×4 topics
- Coronavirus4▲ 33×3 topics
- Viral Transmission3▲ 45×3 topics
- Inflammation3▲ 2.8×19 topics
- Mutation3▲ 32×2 topics
- antibody3▲ 57×1 topic
- spike protein3▲ 57×1 topic
- Monoclonal Antibodies3▲ 57×3 topics
- Pathogenesis2▲ 8.9×13 topics
- Therapeutic Antibodies2▲ 60×2 topics
- Glycosylation2▲ 37×3 topics
- Thrombosis2▲ 14×2 topics
- Fibrosis2▲ 19×4 topics
- Clinical Characteristics2▲ 30×1 topic
- Cytokine Storm2▲ 36×1 topic
- Pathophysiology2▲ 13×3 topics
- Antiviral Therapy2▲ 36×3 topics
- Heart Failure2▲ 7.9×6 topics
- Antibody Engineering2▲ 57×1 topic
- Fc Receptors2▲ 57×1 topic
- Insulin Resistance2▲ 7.0×5 topics
- Liver Disease2▲ 35×3 topics
- Hepatocellular Carcinoma2▲ 14×2 topics
- Hypertrophy2▲ 40×2 topics
- Innate Immunity2▲ 8.4×4 topics
- TGF-ß2▲ 17×2 topics
- Immunogenicity1▲ 60×3 topics
- Biopharmaceuticals1▲ 45×3 topics
- Cancer Immunotherapy1▲ 16×2 topics
- Epithelial-Mesenchymal Transition1▲ 25×2 topics
- Idiopathic Pulmonary Fibrosis1▲ 49×1 topic
- Interstitial Lung Disease1▲ 35×1 topic
- Mitochondrial Dysfunction1▲ 8.0×4 topics
- Antigen Presentation1▲ 25×2 topics
Which research topics does VIR Biotechnology (United States) publish most on?
By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Monoclonal and Polyclonal Antibodies Research and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 3 works
- 2 COVID-19 Clinical Research Studies Infectious Diseases 2 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 4 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 1 works
- 5 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
- 6 Hepatitis B Virus Studies Epidemiology 1 works
- 7 Long-Term Effects of COVID-19 Neurology 1 works
- 8 Influenza Virus Research Studies Epidemiology 1 works
- 9 Immunotherapy and Immune Responses Immunology 1 works
- 10 Osteoarthritis Treatment and Mechanisms Rheumatology 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has VIR Biotechnology (United States)'s research output changed?
Output in 2022-2025 was 68% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is VIR Biotechnology (United States) as a percentage of every work published that year, 0.00028% in 2024.
Fractional works of VIR Biotechnology (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in San Francisco
- University of California, San Francisco
- San Francisco State University
- University of San Francisco
- Institute on Aging
- Golden Gate University
- Bechtel (United States)
- University of California Hastings College of the Law
- Cal Humanities
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about VIR Biotechnology (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
